Optic neuritis after COVID‐19 vaccine application
Christian García‐Estrada, Enrique Gómez‐Figueroa, L. Albán, Alejandro Arias‐Cárdenas
Abstract
As the COVID-19 pandemic continues to rise, the development of effective vaccines is of crucial importance to prevent further morbidity and mortality. In parallel, some rare adverse events related to COVID-19 vaccines, have been reported, most of them mild. Here we report the case of a previously healthy 19-year-old woman who developed optic neuritis 1 week after single dose of Ad26.COV2.S vaccine with marked improvement after management with steroids. Although causality cannot be confirmed due to lack of a biological marker, this case may help to guide further research for potential pathogenic mechanism.
Topics & Concepts
Optic neuritisMedicineCoronavirus disease 2019 (COVID-19)PandemicAdverse effectCausality (physics)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakIntensive care medicineMultiple sclerosisVirologyPediatricsImmunologyInternal medicineOutbreakDiseaseQuantum mechanicsPhysicsInfectious disease (medical specialty)Retinal and Optic ConditionsSARS-CoV-2 and COVID-19 ResearchPeripheral Neuropathies and Disorders